Assay Detail
Binding
CHEMBL4416110
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Inhibition of GST-tagged human EGFR D770GY mutant using poly(Glu, Tyr) 4:1 substrate incubated for 120 mins by kinase-Glo plus luminescent kinase assay
6
Total Activities
6
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Binding |
| Organism | Homo sapiens |
| Confidence | 0 — Uncurated / Unknown |
| Curated By | Autocuration |
Publication
Discovery of a Furanopyrimidine-Based Epidermal Growth Factor Receptor Inhibitor (DBPR112) as a Clinical Candidate for the Treatment of Non-Small Cell Lung Cancer.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| IC50 | 6 | 9.45 | 10.48 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL4521381 | — | — | 1 | 10.48 |
| CHEMBL3545154 | POZIOTINIB | 3.0 | 1 | 10.09 |
| CHEMBL4559807 | — | — | 1 | 9.53 |
| CHEMBL4514452 | — | — | 1 | 9.19 |
| CHEMBL3353410 | OSIMERTINIB | 4.0 | 1 | 9.07 |
| CHEMBL4534719 | — | — | 1 | 8.32 |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL4521381 | — | IC50 | = | 0.033 | nM | 10.48 |
| CHEMBL3545154 | POZIOTINIB | IC50 | = | 0.082 | nM | 10.09 |
| CHEMBL4559807 | — | IC50 | = | 0.295 | nM | 9.53 |
| CHEMBL4514452 | — | IC50 | = | 0.641 | nM | 9.19 |
| CHEMBL3353410 | OSIMERTINIB | IC50 | = | 0.858 | nM | 9.07 |
| CHEMBL4534719 | — | IC50 | = | 4.82 | nM | 8.32 |